[144] Cardinal Health, Inc. SEC Filing

Rhea-AI Filing Summary

Cardinal Health Form 144 notice: The filing reports a proposed sale of 13,500 shares of common stock through Merrill (Columbus, OH) with an aggregate market value of $2,009,030NYSE and total shares outstanding are reported as 238,793,647. The approximate sale date is 08/19/2025. The shares to be sold were acquired mostly on 08/15/2025 as restricted and performance stock vesting (3,863 restricted; 9,318 performance) and a smaller tranche on 02/15/2025 (319 restricted).

The filer certifies there are no undisclosed material adverse facts and notes no sales in the past three months. This is a routine insider sale notice required under Rule 144 describing the broker, quantity, acquisition dates and nature of acquisition.

Positive

• Complete transaction detail provided: broker, share count, aggregate value, exchange and approximate sale date are all disclosed
• Acquisition types disclosed: restricted stock and performance stock vesting dates are listed, improving transparency
• No prior sales reported in the past three months, simplifying Rule 144 aggregation

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for a modest insider sale; provides standard disclosure of vested shares and broker details.

The filing documents a proposed disposition of 13,500 Cardinal Health common shares via Merrill with market value shown at $2,009,030 and an expected sale date of 08/19/2025. Acquisition details list restricted and performance stock vesting on 08/15/2025 and a small restricted grant on 02/15/2025. No sales reported in the prior three months. This is a compliance-focused disclosure that gives investors transparency into insider liquidity but does not itself provide operational or financial performance information.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 elements; the representation about no undisclosed material information is standard and important for compliance.

The notice includes the seller relationship to the issuer, broker identity, share counts, acquisition dates and types (restricted and performance stock vesting), and a certification about material information. Such filings are typical when insiders sell vested equity and serve to document compliance with securities-law resale conditions. The absence of reported sales in the prior three months simplifies aggregation considerations under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Dr 5th Flr Columbus OH 43240	13500	2009030.00	238793647	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Restricted stock vest	Cardinal Health			3863	08/15/2025	NA
Common	08/15/2025	Performance stock vest	Cardinal Health			9318	08/15/2025	NA
COmmon	02/15/2025	Restricted stock vest	Cardinal Health			319	02/15/2025	na

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is the proposed sale reported in the Cardinal Health (CAH) Form 144?

The notice reports a proposed sale of 13,500 shares of Cardinal Health common stock with an aggregate market value of $2,009,030 via Merrill.

When is the approximate sale date for the shares in this filing?

The filing lists the approximate date of sale as 08/19/2025.

How were the shares being sold acquired according to the Form 144?

Shares were acquired through restricted stock vesting and performance stock vesting on 08/15/2025 (3,863 restricted; 9,318 performance) and a restricted vest on 02/15/2025 (319).

Which broker is handling the proposed sale in the filing?

The broker named is Merrill with an address listed at 8890 Lyra Dr, 5th Flr, Columbus, OH 43240.

Does the Form 144 report any securities sold by the filer in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months.